These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15205667)

  • 1. Induction of heme oxygenase-1 before conditioning results in improved survival and reduced graft-versus-host disease after experimental allogeneic bone marrow transplantation.
    Gerbitz A; Ewing P; Wilke A; Schubert T; Eissner G; Dietl B; Andreesen R; Cooke KR; Holler E
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):461-72. PubMed ID: 15205667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation.
    Ewing P; Hildebrandt GC; Planke S; Andreesen R; Holler E; Gerbitz A
    Int J Mol Med; 2007 Sep; 20(3):301-8. PubMed ID: 17671733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1.
    Woo J; Iyer S; Mori N; Buelow R
    Transplantation; 2000 Feb; 69(4):623-33. PubMed ID: 10708121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of heme oxygenase-1 in the donor reduces graft immunogenicity.
    Martins PN; Kessler H; Jurisch A; Reutzel-Selke A; Kramer J; Pascher A; Pratschke J; Neuhaus P; Volk HD; Tullius SG
    Transplant Proc; 2005; 37(1):384-6. PubMed ID: 15808653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.
    Tullius SG; Nieminen-Kelhä M; Buelow R; Reutzel-Selke A; Martins PN; Pratschke J; Bachmann U; Lehmann M; Southard D; Iyer S; Schmidbauer G; Sawitzki B; Reinke P; Neuhaus P; Volk HD
    Transplantation; 2002 Sep; 74(5):591-8. PubMed ID: 12352873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 alleviates mouse hepatic failure through suppression of adaptive immune responses.
    Gu Q; Wu Q; Jin M; Xiao Y; Xu J; Mao C; Zhao F; Zhang Y; Zhang Y
    J Pharmacol Exp Ther; 2012 Jan; 340(1):2-10. PubMed ID: 21946119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression.
    Chauveau C; Rémy S; Royer PJ; Hill M; Tanguy-Royer S; Hubert FX; Tesson L; Brion R; Beriou G; Gregoire M; Josien R; Cuturi MC; Anegon I
    Blood; 2005 Sep; 106(5):1694-702. PubMed ID: 15920011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.
    Li M; Kim DH; Tsenovoy PL; Peterson SJ; Rezzani R; Rodella LF; Aronow WS; Ikehara S; Abraham NG
    Diabetes; 2008 Jun; 57(6):1526-35. PubMed ID: 18375438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution.
    Bouazzaoui A; Dickhöfer S; Kreuz M; Huber E; Holler E; Wolff D
    Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):158-64. PubMed ID: 24588615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
    Bédard EL; Jiang J; Parry N; Wang H; Liu W; Garcia B; Kim P; Chakrabarti S; Buelow R; Zhong R
    Transpl Int; 2005 Mar; 18(3):341-9. PubMed ID: 15730496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
    Hill GR; Teshima T; Gerbitz A; Pan L; Cooke KR; Brinson YS; Crawford JM; Ferrara JL
    J Clin Invest; 1999 Aug; 104(4):459-67. PubMed ID: 10449438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32).
    Woo J; Iyer S; Cornejo MC; Mori N; Gao L; Sipos I; Maines M; Buelow R
    Transpl Immunol; 1998 Jun; 6(2):84-93. PubMed ID: 9777696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of intestinal haem-oxygenase-1 (HO-1) in clinical and experimental colitis.
    Paul G; Bataille F; Obermeier F; Bock J; Klebl F; Strauch U; Lochbaum D; Rümmele P; Farkas S; Schölmerich J; Fleck M; Rogler G; Herfarth H
    Clin Exp Immunol; 2005 Jun; 140(3):547-55. PubMed ID: 15932518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid B ameliorates liver injury in a murine aGvHD model by decreasing inflammatory responses via upregulation of HO-1.
    Zhao J; Yang XC; Fujino M; Ichimaru N; Que W; Li XK; Takahara S
    Transpl Immunol; 2019 Aug; 55():101203. PubMed ID: 30904623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.